SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-013250
Filing Date
2023-08-03
Accepted
2023-08-03 16:26:35
Documents
52
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nxtc-20230630x10q.htm   iXBRL 10-Q 1112796
2 EX-31.1 nxtc-20230630xex31d1.htm EX-31.1 12901
3 EX-31.2 nxtc-20230630xex31d2.htm EX-31.2 12682
4 EX-32.1 nxtc-20230630xex32d1.htm EX-32.1 12241
  Complete submission text file 0001558370-23-013250.txt   4743821

Data Files

Seq Description Document Type Size
5 EX-101.SCH nxtc-20230630.xsd EX-101.SCH 28809
6 EX-101.CAL nxtc-20230630_cal.xml EX-101.CAL 38351
7 EX-101.DEF nxtc-20230630_def.xml EX-101.DEF 101018
8 EX-101.LAB nxtc-20230630_lab.xml EX-101.LAB 310162
9 EX-101.PRE nxtc-20230630_pre.xml EX-101.PRE 203972
46 EXTRACTED XBRL INSTANCE DOCUMENT nxtc-20230630x10q_htm.xml XML 851249
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Filer) CIK: 0001661059 (see all company filings)

IRS No.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38905 | Film No.: 231140490
SIC: 2834 Pharmaceutical Preparations